Source: default.yaml | Run started: 2026-02-28 19:38:55
============================================================
extraction_prompts
{'Reason_for_Visit': 'TASK: Extract 'Reason for Visit'.
Be SPECIFIC — include the patient's diagnosis, cancer type, and the purpose of this visit.
Do NOT give vague answers like "new symptoms" or "follow up visit". Instead, state what cancer,
what stage (if known), and what specifically brought them in (e.g., "initial consult for newly
diagnosed metastatic ER+ breast cancer" or "cycle 3 day 1 of irinotecan for metastatic TNBC").
Respond *only* with a JSON object using this exact schema:
{
"Patient type": "either New patient or follow up",
"second opinion": "whether the visit is consultation/second opinion or not",
"in-person": "either Televisit or in-person. (note, video consult, televisit, telehealth are the same thing)",
"summary": "A specific summary including cancer type, stage if known, and purpose of this visit."
}
', 'What_We_Found': 'TASK: Extract 'What We Found'.
For lab_summary, list SPECIFIC lab values and results (e.g., "Hgb 7.7, Albumin 2.1, Alk Phos 183").
Do NOT substitute imaging results for lab results.
For findings, summarize NEW clinical findings or current disease status from this visit.
Respond *only* with a JSON object using this exact schema:
{
"Type_of_Cancer": "list the type of cancer",
"Stage_of_Cancer": "list the stage if it is written in the note",
"Distant Metastasis": "if there is distant metastasis (met). Yes, to where; No, local, not sure, need more evidence such as imaging.",
"Metastasis": "if there is met, Yes (to where), No, or Not sure",
"lab_summary": "Summary of key lab results with specific values. Only include laboratory tests (blood work), NOT imaging.",
"findings": "Summary of new findings or disease status."
}
', 'Treatment_Summary': 'TASK: Extract 'Treatment Summary'.
Respond *only* with a JSON object using this exact schema:
{
"current_meds": "List of current oncologic medications or regimens.",
"recent_changes": "Any holds, dose reductions, or switches.",
"supportive_meds": "List of supportive medications."
}
', 'Goals_of_care': 'TASK: Extract 'What We Discussed / Decided'.
Respond *only* with a JSON object using this exact schema:
{
"goals_of_treatment": "eg, cancer is not curable, but it's treatable and the goal is to extend the duration and maintain the quality of life",
"response_assessment": "How the cancer is responding to the treatment, not responding or responding."
}
'}
============================================================
plan_extraction_prompts
{'Medication_Plan_chatgpt': 'TASK: Extract the 'Medication Plan' from the given 'Assessment/Plan' section.
Include all current and future medication plans for both cancer therapy and supportive treatment. Cancer treatment could be one or many in chemotherapy, hormonal therapy, bone therapy, radiotherapy (eg. rad onc, xrt). Supportive treatment could be one or many in bowel regimen, pain medication, psychiatry medication, neuropathy or any blood transfusion plan.

IMPORTANT classification rules:
- "bowel regimen" means laxatives, stool softeners, anti-diarrheals (e.g., docusate, miralax, lomotil, imodium). Antibiotics like doxycycline are NOT bowel regimen — classify them under "other treatment" or "infection management".
- "pain medication" means analgesics (opioids, NSAIDs, muscle relaxants for pain).
- "psychiatry medication" means antidepressants, anxiolytics, antipsychotics.

Include whether a medication is being started now (e.g,"will start", "Rx sent", "starting today" ), plan or discuss in the future after certain condition (e.g., "plan to start after radiation", "discussed addition of…"), continue or maintained("continue"), stop or change.

Include an alterative, second-line or clinical trials options if dicussed.
Include an 'other treatment' section for any other medications that only briefly mentioned in the plan section.
Respond *only* with a JSON object using this exact schema:
{
    "The medication/treatment, one of chemotherapy, hormonal therapy, bone therapy, radiotherapy":
{"summary":"the summary of this type of medication, including start/stop/cotinue if applicable",
"Short term side_effects_discussed": "short term Side effects of this particular medications.",
"Long term side_effects_discussed": "long term Side effects of this particular medications.."}
}
', 'Medication_Plan': 'TASK: Extract the 'Medication Plan' from the given 'Assessment/Plan' section.
Include future medication plans, changes to current meds (start, stop, continue), supportive meds, bowel regimen, and any blood transfusion plan. Do not include past medications.
Be SPECIFIC: list actual drug names, doses, and frequencies when mentioned. Do NOT use vague terms like "will start medications".
Respond *only* with a JSON object using this exact schema:
{
    "medication_plan": "A summary of the complete medication plan with specific drug names and doses."
}
', 'Therapy_plan': 'TASK: Extract the 'therapy Plan' from the given 'Assessment/Plan' section.
Include ONLY current or future therapy: chemotherapy, radiotherapy, hormonal therapy, and bone-therapy.
Include future plans, changes to current therapy (start, stop, continue).

CRITICAL — distinguish PAST from CURRENT/FUTURE:
- PAST (DO NOT include): "underwent mastectomy in 2016", "s/p colectomy", "completed 6 cycles of TCHP", "had radiation in 2018"
- CURRENT (include): "continue letrozole", "currently on irinotecan", "taking tamoxifen daily"
- FUTURE (include): "will start", "plan to begin", "discussed starting", "switch to"

Be SPECIFIC: include drug names, doses, schedule changes, and cycle information when mentioned.
Respond *only* with a JSON object using this exact schema:
{
    "therapy_plan": "A summary of the current and future therapy plan with specific details."
}
', 'radiotherapy_plan': 'TASK: Extract the 'radiotherapy Plan' from the given 'Assessment/Plan' section.
For radiotherapy, include ANY statement that indicates
it is being considered, recommended, or may be used, even if no explicit
start/continue/plan keywords are present.
Include referrals to radiation oncology (Rad Onc) as a radiotherapy-related plan.
Respond *only* with a JSON object using this exact schema:
{
    "radiotherapy_plan": "A summary of any planned or discussed radiotherapy, or 'None' if not mentioned."
}
', 'Procedure_Plan': 'TASK: Extract the 'Procedure Plan' from the given 'Assessment/Plan' section.
Include ONLY future/planned procedures: surgery, biopsy, lumbar puncture, Chemo Port Insertion, or other interventional procedures.

CRITICAL — distinguish PAST from FUTURE:
- PAST (DO NOT include): "underwent mastectomy on 10/29/16", "s/p colectomy in June 2018", "had biopsy on 05/25", "completed radiation"
- FUTURE (include): "will schedule biopsy", "plan for port placement", "surgery pending", "scheduled for colectomy next week"
If a procedure has a past date or uses past tense (underwent, had, completed, s/p), it is PAST — do NOT include it.

Also DO NOT include:
- Imaging plans (CT, MRI, PET — these go in Imaging Plan)
- Lab plans
- Medication plans
- Referrals or consultations (e.g., "XRT consult" is a referral, not a procedure)
If no future procedures are planned, say "No procedures planned."
Respond *only* with a JSON object using this exact schema:
{
    "procedure_plan": "A summary of any planned procedures, or 'No procedures planned.'"
}
', 'Imaging_Plan': 'TASK: Extract the 'Imaging Plan' from the given 'Assessment/Plan' section.
Include ONLY future/planned imaging: CT, MRI, PET/CT, ultrasound, DEXA scans, bone scan, X-ray.
Include timing and rationale if mentioned (e.g., "CT in 3 months for restaging").

CRITICAL — distinguish PAST from FUTURE:
- PAST (DO NOT include): "MRI showed lesions", "CT on 12/24/2019 showed...", "bone density scan last July showed..."
- FUTURE (include): "will order MRI", "DEXA in 1 year, due July 2019", "scans again in 3 months", "annual mammogram next due July 2019", "consider brain MRI if worsening"

DO NOT include any procedure plan, lab plan, or medication plan.
List SPECIFIC imaging types. Do NOT use vague terms like "staging workup".
If no future imaging is planned, say "No imaging planned."
Respond *only* with a JSON object using this exact schema:
{
    "imaging_plan": "A summary of any planned imaging with specific test names, or 'No imaging planned.'"
}
', 'Lab_Plan': 'TASK: Extract the 'lab Plan' from the given 'Assessment/Plan' section.
Include ONLY future/planned labs: CBC, CMP, tumor markers (CA 15-3, CEA, CA-125, PSA), coagulation profile, hepatitis markers, etc.
Specify frequency and rationale if mentioned.
DO NOT include past lab results. DO NOT use vague terms like "staging workup" — list the specific tests ordered.
If no future labs are planned, say "No labs planned."
Respond *only* with a JSON object using this exact schema:
{
    "lab_plan": "A summary of the future lab plan with specific test names, or 'No labs planned.'"
}
', 'Genetic_Testing_Plan': 'TASK: Extract the 'Genetic Testing Plan' from the given 'Assessment/Plan' section.

1. Scope of section:
- First, find the 'Assessment/Plan' section of the note (usually the final section).
- Only look for plans that are clearly about FUTURE genetic or molecular TESTING.

2. What COUNTS as 'genetic or molecular testing':
- Diagnostic, prognostic, or predictive laboratory assays, such as:
  - Tumor genomic sequencing / NGS / panel testing
  - Germline genetic panels (e.g., hereditary cancer panel, BRCA testing)
  - Liquid biopsy / circulating tumor DNA (ctDNA) tests
  - Specific biomarker tests (e.g., PD-L1 testing, MSI testing, EGFR mutation testing)
  - Any plan to "send", "order", "check", or "obtain" a genetic, genomic, or molecular TEST

3. What MUST be EXCLUDED:
- DO NOT include any medications, systemic therapies, or treatment plans:
  - Chemotherapy, immunotherapy, targeted therapies (e.g., FGFR inhibitor, PARP inhibitor, CDK4/6 inhibitor, TKIs)
  - Hormonal therapy, radiation therapy, surgery
  - Clinical trial options, even if the trial involves targeted drugs or inhibitors
- DO NOT include tests that are already completed, historic, or only mentioned in past oncology history.
- DO NOT include imaging (CT, PET, MRI, X-ray, ultrasound) or routine labs (CBC, CMP).

4. If there is NO new genetic or molecular test planned in the Assessment/Plan:
- Set the value to a clear negative statement, for example:
  "No new genetic or molecular tests were planned during this visit."

5. Output format:
Respond *only* with a JSON object using this exact schema:
{
    "genetic_testing_plan": "A summary of any future planned genetic or molecular tests, or a clear statement that none are planned."
}
', 'Referral': 'TASK: Extract 'Referral' from the given 'Assessment/Plan' section.
Do not mistake the doctor's signature at the end of the note as a referral.
Include ALL referrals mentioned, including integrative medicine, complementary medicine, or wellness referrals.
A "consult" (e.g., "XRT consult", "Rad Onc consult") counts as a Specialty referral.
If no referral is mentioned for a category, set its value to "None".
Respond *only* with a JSON object using this exact schema:
{
"Nutrition": "any nutrition referrals such as diet optimization, appetite, weight maintenance, or 'None'",
"Genetics": "eg, germline testing, family counseling, or 'None'",
"Specialty": "eg, Palliative care, Radiation oncology consult, surgical oncology, Integrative Medicine, Psychology/psychiatry, or 'None'",
"Others": "Physical or occupational therapy, Social work, financial counseling, home health, or 'None'",
"follow up": "follow up mentioned in the provided text. f/up, f/p and fup all mean follow up."
}
', 'follow_up_next_visit': 'TASK: Extract the 'follow up/next visit' from the given 'Assessment/Plan' section.
Be SPECIFIC about timing (e.g., "2 weeks", "after biopsy results", "3 months").
Respond *only* with a JSON object using this exact schema:
{
    "Next clinic visit": "(in-person or telehealth): timing and purpose"
}
', 'Advance_care_planning': 'TASK: Extract the 'Advance care planning' from the given 'Assessment/Plan' section.
Include Advance directives, health-care proxy, code status (e.g., Full code, DNR/DNI).
If a code status is mentioned anywhere in the note, include it.
If no advance care planning is discussed, say "Not discussed during this visit."
Respond *only* with a JSON object using this exact schema:
{
    "Advance care": "A summary of any advance care planning including code status, or 'Not discussed during this visit.'"
}
'}
============================================================











============================================================
RESULTS FOR ROW 6
============================================================

--- Column: coral_idx ---
145

--- Column: note_text ---
"  HPI:  ***** ***** is a 34 y.o. female with ER+/PR+ IDC of the right breast.     On June 21 she underwent a partial mastectomy with sentinel node biopsy with expander placement. She reports recovering well although is still experiencing tightness in the area.     Experiences night sweats for four days after injection. Otherwise manageable.     Patient Active Problem List    Diagnosis Date Noted   \u0007 Breast Cancer Right 04/25/2019     December 2018 self-palpated right breast mass  03/05/2019 Bilateral breast US (***** ***** Hospital in *****): 6x7 mm mass with ductal extension at 1 o'clock, likely DCIS.   03/17/2019 Gynecology at ***** for lower abdomen swelling, urethral discomfort and breast mass in the breast US (*****). On exam 1 cm firm, mobile, nontender mass approximately 5 cm from nipple at 1 o'clock.  03/17/2019: Right breast FNA at 1 o'clock (UCSF): Benign and could be seen in the setting of fibrocystic change or fibroadenoma.  03/17/2018 Abdomen-pelvic CT: No acute findings (for abdominal pain).  03/28/2019 Bilateral breast diagnostic mammogram (UCSF): A focal asymmetry is suggested in the region. Triangular marker denotes site of focal pain in the lower slightly outer right breast, with no underlying mammographic correlate. Scattered and occasionally grouped benign-appearing microcalcifications, both breasts, predominantly coarse dystrophic, likely the sequelae of reported fat grafting.  03/28/2019 Bilateral breast diagnostic US(UCSF): 22 x 10 x 15 mm oval complex solid and cystic mass with peripheral echogenicity and an irregular, antiparallel hypoechoic central component in the right upper inner quadrant, 1:00, 8 cm from nipple. The central hypoechoic component measures up to 10 mm. No sonographic correlate to site of focal pain in the lower outer right breast at 7 o'clock, 5 cm from nipple. No sonographic correlate to clinician's site of concern in the left axilla. A few normal-appearing nodes are identified. \n Left breast: benign  03/30/2019 Right breast US guided core biopsy at 1 o'clock 8 cm from nipple (UCSF): Grade 1 IDC, ER+(>95%), PR(~90% ranging from weak to strong nuclear staining), ***** equivocal(IHC 2), FISH non-amplified (0.55 cm largest dimension in a core; multiple core involved), *****-67: ~10%. Focal atypical ductal hyperplasia. Pseudoangiomatous stromal hyperplasia. DCIS not present.  04/24/2019 Dr. ***** at *****. genetics referral   04/24/2019 Dr. ***** at *****: discussed bilateral ***** with expander/implant reconstruction  04/25/2019 Dr. ***** (Surgeon) discussed surgical options lumpectomy vs bilateral mastectomy, recommended genetic testing.  04/25/2019 Myriad Genetic Result: Negative  05/08/2019 Dr. ***** (***** *****) planned double mastectomy with reconstruction with Dr. ***** ***** (CPMC)  05/24/2019 ***** (*****): Low risk: +0.287  06/08/19 zoladex  06/21/19 bilateral mastectomy and expanders  Left breast: benign  Right breast: 15 x 10 mm grade I IDC, Extensive DCIS (*****-3); 0/1 nodes.  *****-95%, PR 90%, ***** not repeated  07/05/19 letrozole     \u0007 Family history of *****'s disease 04/25/2019   \u0007 Bipolar 2 disorder (HCC) 04/04/2019   \u0007 Insomnia 04/04/2019       PAST MEDICAL/SURGICAL HISTORY, FAMILY HISTORY AND SOCIAL HISTORY: were reviewed and updated as appropriate.      Current Outpatient Medications:   \u0007  ascorbic acid, vitamin C, 500 mg *****, Take by mouth daily., Disp: , Rfl:   \u0007  B-complex with vitamin C tablet, Take by mouth daily., Disp: , Rfl:   \u0007  estradioL (*****) 2 mg (7.5 mcg /24 hour) vaginal ring, Use as instructed, Disp: 1 each, Rfl: 4  \u0007  fluticasone propionate (FLONASE) 50 mcg/actuation nasal spray, INSTILL 1 TO 2 SPRAYS ***** ***** ***** ONCE DAILY, Disp: , Rfl:   \u0007  gabapentin (NEURONTIN) 300 mg capsule, Take 1 capsule (300 mg total) by mouth 3 (three) times daily, Disp: 90 capsule, Rfl: 3  \u0007  ***** ***** ORAL, Take by mouth. ***** tincture-  Use 1/2 -1 teaspoon by mouth ***** \n for anxiety, Disp: , Rfl:   \u0007  Lactobacillus acidophilus (PROBIOTIC ORAL), Take 1 capsule by mouth. PROBIOTIC-10PO, Disp: , Rfl:   \u0007  lamoTRIgine (LAMICTAL XR) 200 mg 24 hr ER tablet, Take 1 tablet (200 mg total) by mouth daily, Disp: 30 tablet, Rfl: 11  \u0007  letrozole (FEMARA) 2.5 mg tablet, Take 1 tablet (2.5 mg total) by mouth daily, Disp: 30 tablet, Rfl: 11  \u0007  loratadine (CLARITIN) 10 mg tablet, TAKE ONE TABLET BY MOUTH DAILY AS NEEDED, Disp: , Rfl:   \u0007  multivitamin capsule, Take 1 capsule by mouth daily. Multiple Vitamin, Disp: , Rfl:   \u0007  naproxen (NAPROSYN) 500 mg tablet, TAKE ONE TABLET BY MOUTH TWICE A DAY, Disp: , Rfl:   \u0007  traMADoL (ULTRAM) 50 mg tablet, Take 50 mg by mouth every 6 (six) hours as needed, Disp: , Rfl:   \u0007  tretinoin microspheres (RETIN-A MICRO *****) 0.08 % *****, Apply 1 Application topically Daily., Disp: 50 g, Rfl: 5  \u0007  TURMERIC ORAL, Take 1 capsule by mouth. TURMERIC PO take 1 cap by mouth daily, Disp: , Rfl:   \u0007  UNABLE TO FIND, Med Name: ***** ***** ***** ***** mouth daily., Disp: , Rfl:   \u0007  zolpidem (AMBIEN) 5 mg tablet, Take 1 tablet (5 mg total) by mouth nightly as needed for Sleep for up to 30 days, Disp: 5 tablet, Rfl: 3    Review of Systems - All other systems were reviewed and are negative except that outlined above.      BP 105/60  | Pulse 65  | Temp 36.5 C (97.7 F) (Temporal)  | Resp 16  | Ht 160.3 cm (5' 3.11\") Comment: 07/04/2019 @***** | Wt 62.2 kg (137 lb 3.2 oz)  | SpO2 99%  | BMI 24.22 kg/m   Physical Examination: General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - pupils equal and reactive, extraocular eye movements intact  Mouth - mucous membranes moist, pharynx normal without lesions  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy  Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm, normal \n S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  Breasts - Bilateral nipple sparing mastectomies with healing inferior scars  One stitch at 12 o'clock in R breast  Mild edema   Resolving ecchymosis in inferior medial aspect of R breast  Back exam - full range of motion, no tenderness, palpable spasm or pain on motion  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted    I personally reviewed and interpreted the following results:  Results for orders placed or performed in visit on 06/08/19   Estradiol, Ultrasensitive   Result Value Ref Range    Estradiol, Ultrasensitive 172 pg/mL   Vitamin D, 25-Hydroxy   Result Value Ref Range    Vitamin D, 25-Hydroxy 24 20 - 50 ng/mL   Comprehensive Metabolic Panel (BMP, AST, ALT, T.BILI, ALKP, TP, ALB)   Result Value Ref Range    Albumin, Serum / Plasma 4.6 3.5 - 5.0 g/dL    Alkaline Phosphatase 60 38 - 108 U/L    Alanine transaminase 48 10 - 61 U/L    Aspartate transaminase 31 5 - 44 U/L    Bilirubin, Total 0.8 0.2 - 1.2 mg/dL    Urea Nitrogen, Serum / Plasma 13 7 - 25 mg/dL    Calcium, total, Serum / Plasma 9.5 8.4 - 10.5 mg/dL    Chloride, Serum / Plasma ***** ***** - 110 mmol/L    Creatinine 0.96 0.55 - 1.02 mg/dL    eGFR if non-African American 77 >60 mL/min    eGFR if African ***** 89 >60 mL/min    Potassium, Serum / Plasma 3.8 3.5 - 5.0 mmol/L    Sodium, Serum / Plasma ***** ***** - 145 mmol/L    Protein, Total, Serum / Plasma 7.6 6.3 - 8.6 g/dL    Carbon Dioxide, Total 25 22 - 29 mmol/L    Anion Gap 10 4 - 14    Glucose, non-fasting 88 70 - 199 mg/dL   Complete Blood Count with Differential   Result Value Ref Range    WBC Count 7.4 3.4 - 10 x10E9/L    RBC \n Count 4.07 4.0 - 5.2 x10E12/L    Hemoglobin 13.4 12.0 - 15.5 g/dL    Hematocrit 38.6 36 - 46 %    MCV 95 80 - 100 fL    MCH 32.9 26 - 34 pg    MCHC 34.7 31 - 36 g/dL    Platelet Count ***** ***** - 450 x10E9/L    Neutrophil Absolute Count 4.65 1.8 - 6.8 x10E9/L    Lymphocyte Abs Cnt 2.24 1.0 - 3.4 x10E9/L    Monocyte Abs Count 0.44 0.2 - 0.8 x10E9/L    Eosinophil Abs Ct 0.06 0.0 - 0.4 x10E9/L    Basophil Abs Count 0.02 0.0 - 0.1 x10E9/L    Imm Gran, Left Shift 0.02 <0.1 x10E9/L       Lab Results   Component Value Date    Alanine transaminase 48 06/08/2019    Aspartate transaminase 31 06/08/2019    Alkaline Phosphatase 60 06/08/2019    Bilirubin, Total 0.8 06/08/2019       Assessment and Plan:  Patient Active Problem List   Diagnosis   \u0007 Bipolar 2 disorder (HCC)   \u0007 Insomnia   \u0007 Breast Cancer Right   \u0007 Family history of *****'s disease     IMP  ***** 34 year old woman with bipolar disorder, and ER/PR+ ***** low risk right breast cancer  Underwent bilateral mastectomy with expanders on 06/21/2019.  Started zoladex one month ago.    Reviewed surgery results.  Left breast benign, right breast with 1.5 cm node neg, grade 1 and ER/PR+ IDC.    Discussed ***** with her psychiatrist who said it could make her manic.  Gabapentin is okay.  Rare hot flashes although she had night sweats after the injection.    Recovering nicely with some residual nerve irritation.    Discussed starting letrozole today.  ***** try to continue the ***** for at least 3 years and can sequence with tamoxifen    Start ***** per her request    Estradiol monthly.    Gabapentin prescribed as needed per her request.    We will document her diagnosis for various aid she can apply for.  She is going to go to school online! And study anthropology.    RTC 3 months or sooner as needed.    Patient ready and able to be educated, verbalizes understanding of information/instructions given.  Treatment options, side effects and nutrition reviewed in detail.  \n Total face to face time: 40  Total counseling time: 35    *****, ***** ***** am acting as a scribe for services provided by ***** *****. *****, MD on *****/*****/***** *****:***** PM    The above scribed documentation accurately reflects the services I have provided.    ***** *****. *****, MD   *****/*****/***** *****:***** PM      \n"

--- Column: assessment_and_plan ---
"Assessment and Plan:  Patient Active Problem List   Diagnosis   \u0007 Bipolar 2 disorder (HCC)   \u0007 Insomnia   \u0007 Breast Cancer Right   \u0007 Family history of *****'s disease     IMP  ***** 34 year old woman with bipolar disorder, and ER/PR+ ***** low risk right breast cancer  Underwent bilateral mastectomy with expanders on 06/21/2019.  Started zoladex one month ago.    Reviewed surgery results.  Left breast benign, right breast with 1.5 cm node neg, grade 1 and ER/PR+ IDC.    Discussed ***** with her psychiatrist who said it could make her manic.  Gabapentin is okay.  Rare hot flashes although she had night sweats after the injection.    Recovering nicely with some residual nerve irritation.    Discussed starting letrozole today.  ***** try to continue the ***** for at least 3 years and can sequence with tamoxifen    Start ***** per her request    Estradiol monthly.    Gabapentin prescribed as needed per her request.    We will document her diagnosis for various aid she can apply for.  She is going to go to school online! And study anthropology.    RTC 3 months or sooner as needed.    Patient ready and able to be educated, verbalizes understanding of information/instructions given.  Treatment options, side effects and nutrition reviewed in detail.  \n Total face to face time: 40  Total counseling time: 35    *****, ***** ***** am acting as a scribe for services provided by ***** *****. *****, MD on *****/*****/***** *****:***** PM    The above scribed documentation accurately reflects the services I have provided.    ***** *****. *****, MD   *****/*****/***** *****:***** PM      \n"

--- Column: keypoints ---
{
  "Reason_for_Visit": {
    "Patient type": "follow up",
    "second opinion": "",
    "in-person": "in-person",
    "summary": "Follow up for ER+/PR+ IDC, stage not specified, to review surgery results and start letrozole"
  },
  "What_We_Found": {
    "Type_of_Cancer": "IDC",
    "Stage_of_Cancer": "",
    "Distant Metastasis": "No",
    "Metastasis": "No",
    "lab_summary": "Estradiol 172 pg/mL, Vitamin D 24 ng/mL, Albumin 4.6 g/dL, Alkaline Phosphatase 60 U/L, Alanine transaminase 48 U/L, Aspartate transaminase 31 U/L, Bilirubin 0.8 mg/dL, Urea Nitrogen 13 mg/dL, Calcium 9.5 mg/dL, Potassium 3.8 mmol/L, Protein 7.6 g/dL, Carbon Dioxide 25 mmol/L, Anion Gap 10, Glucose 88 mg/dL, WBC Count 7.4 x10E9/L, Hemoglobin 13.4 g/dL, Hematocrit 38.6 %, MCV 95 fL, MCH 32.9 pg, MCHC 34.7 g/dL, Neutrophil Absolute Count 4.65 x10E9/L, Lymphocyte Abs Cnt 2.24 x10E9/L, Monocyte Abs Count 0.44 x10E9/L, Eosinophil Abs Ct 0.06 x10E9/L, Basophil Abs Count 0.02 x10E9/L",
    "findings": "Patient recovering nicely with some residual nerve irritation, mild edema, and resolving ecchymosis in the right breast"
  },
  "Treatment_Summary": {
    "current_meds": "Letrozole 2.5 mg tablet, Estradiol 2 mg vaginal ring, Gabapentin as needed, Zoladex",
    "recent_changes": "",
    "supportive_meds": "Gabapentin, Zoladex"
  },
  "Goals_of_care": {
    "goals_of_treatment": "To continue treatment for at least 3 years and sequence with tamoxifen",
    "response_assessment": ""
  },
  "Medication_Plan_chatgpt": {
    "hormonal therapy": {
      "summary": "plan to start Letrozole today, will continue for at least 3 years, can sequence with Tamoxifen",
      "Short term side_effects_discussed": "rare hot flashes, night sweats after injection",
      "Long term side_effects_discussed": ""
    },
    "psychiatry medication": {
      "summary": "prescribed as needed",
      "Short term side_effects_discussed": "",
      "Long term side_effects_discussed": ""
    },
    "other treatment": {
      "summary": "Estradiol monthly",
      "Short term side_effects_discussed": "",
      "Long term side_effects_discussed": ""
    }
  },
  "Medication_Plan": {
    "medication_plan": "Gabapentin as needed, Letrozole, Estradiol monthly"
  },
  "Therapy_plan": {
    "therapy_plan": "will start Letrozole, plan to continue for at least 3 years, can sequence with Tamoxifen"
  },
  "radiotherapy_plan": {
    "radiotherapy_plan": "discussed"
  },
  "Procedure_Plan": {
    "procedure_plan": "No procedures planned."
  },
  "Imaging_Plan": {
    "imaging_plan": "MRI"
  },
  "Lab_Plan": {
    "lab_plan": "No labs planned."
  },
  "Genetic_Testing_Plan": {
    "genetic_testing_plan": "No new genetic or molecular tests were planned during this visit."
  },
  "Referral": {
    "Nutrition": "None",
    "Genetics": "None",
    "Specialty": "Radiation oncology",
    "Others": "None",
    "follow up": "None"
  },
  "follow_up_next_visit": {
    "Next clinic visit": "3 months or sooner as needed"
  },
  "Advance_care_planning": {
    "Advance care": "Not discussed during this visit."
  }
}
